Kiniksa Pharmaceuticals International (KNSA) Other Non Operating Income (2022 - 2026)
Kiniksa Pharmaceuticals International (KNSA) recorded Other Non Operating Income of $3.95 million in Q2 2026, up 45.4% from $2.72 million a year earlier and up 15.7% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Other Non Operating Income (2022 - 2026) Analysis & Trends
On a TTM basis, Kiniksa Pharmaceuticals International's Other Non Operating Income came in at $14 million as of Jun 30, 2026, up 43.1% year-over-year; for FY2025, it came in at $11.65 million, up 23.1% from FY2024.
- Annual Other Non Operating Income has increased for three straight years, with a five-year compound annual growth rate of 59.3% (FY2020 to FY2025).
- Across earlier years, Other Non Operating Income came in at $9.46 million in FY2024 (+10.8%), $8.54 million in FY2023 (+581.9%), $1.25 million in FY2022 and $97,000 in FY2021 (-91.4%).
- The Q2 2026 figure is the highest quarterly Other Non Operating Income in data going back to Q1 2022.
- On a year-over-year basis, Other Non Operating Income has increased for six consecutive quarters, with growth averaging 23.2% over the last eight quarters.
- Peak year-over-year performance for Other Non Operating Income in the last five years was growth of 654.0% in Q3 2023, against a decline of 2.1% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.41 million (Q1 2026), $3.5 million (Q4 2025) and $3.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.82 Bn | 10.56 Bn | 220.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.95 Mn |
| Mar 31, 2026 | 3.41 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 3.14 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 2.32 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 2.43 Mn |
| Jun 30, 2023 | 1.92 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 794,000.00 |
| Sep 30, 2022 | 322,000.00 |
| Jun 30, 2022 | 103,000.00 |
| Mar 31, 2022 | 34,000.00 |
API Access
Kiniksa Pharmaceuticals International Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();